Back to Epoch Investment Partners, Inc.

REGN
Showing 8 of 9 quarters

Position history for Epoch Investment Partners, Inc.'s holdings in REGENERON PHARMACEUTICALS

Epoch Investment Partners, Inc. holds 238,725 shares of REGN (REGENERON PHARMACEUTICALS), worth $184.4M as of 2026-Q1. The position was decreased (-15.2% shares). REGN represents 1.1% of Epoch Investment Partners, Inc.'s portfolio.

Current Value

$184.4M

Current Shares

238,725

Total Value Change

+$12.8M

Total Shares Change

+75,429

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
238,725
-15.2%
$184.4M1.1%$766.66
0
2025-Q4
Increased
281,335
+8.6%
$217.2M1.2%$773.94
52
2025-Q3
Increased
259,153
+27.6%
$145.7M0.8%$560.05
53
2025-Q2
Decreased
203,057
-2.1%
$106.6M0.6%$519.56
0
2025-Q1
Increased
207,456
+5.2%
$131.6M0.7%$634.66
45
2024-Q4
Increased
197,266
+25.1%
$140.5M0.7%$698.71
52
2024-Q3
Decreased
157,740
-3.4%
$165.8M0.7%$1,036.94
0
2024-Q2
Increased
163,296
+57.7%
$171.6M0.8%$1,045.23
61

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used